For instance, tandem anti-HER2 and IL13Rα2 CAR-NK cells exhibited a 40% increase in cytotoxic efficiency against dual-antigen–positive cells compared with single-antigen CARs in glioblastoma models, while also markedly decreasing the probability of therapeutic failure associated with antigen loss [55]. Here, IL13RA2 is linked to glioblastoma.